Liu Liu

Department Of Oral And Maxillofacial Head & Neck Oncology
Shanghai, 200011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Serum metabolomics reveals distinctive signature of cancer staging in oral squamous cell carcinoma.

Serum metabolomics reveals distinctive signature of cancer staging in oral squamous cell carcinoma.

Journal: BMC oral health

Published: June 03, 2025

YY1 Induced FOXD2-AS1 Drives Proliferation of Oral Squamous Cell Carcinoma Through EZH2/CDKN1A Axis.

YY1 Induced FOXD2-AS1 Drives Proliferation of Oral Squamous Cell Carcinoma Through EZH2/CDKN1A Axis.

Journal: Oral diseases

Published: February 26, 2025

Author Correction: FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression.

Author Correction: FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression.

Journal: International journal of oral science

Published: July 02, 2024

Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression by Modulating Autophagy.

Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression by Modulating Autophagy.

Journal: Oral diseases

Published: April 09, 2024

Stabilization of EREG via STT3B-mediated N-glycosylation is critical for PDL1 upregulation and immune evasion in head and neck squamous cell carcinoma.

Stabilization of EREG via STT3B-mediated N-glycosylation is critical for PDL1 upregulation and immune evasion in head and neck squamous cell carcinoma.

Journal: International journal of oral science

Published: November 26, 2023

FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression.

FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression.

Journal: International journal of oral science

Published: October 31, 2023

Evaluating photodynamic therapy for oral precancerous lesions: Highlighting outcome measure of malignant transformation.

Evaluating photodynamic therapy for oral precancerous lesions: Highlighting outcome measure of malignant transformation.

Journal: Journal of dental sciences

Published: October 06, 2023

20 abnormal metabolites of Stage IV Grade C periodontitis was discovered by CPSI-MS.

20 abnormal metabolites of Stage IV Grade C periodontitis was discovered by CPSI-MS.

Journal: Pathology oncology research : POR

Published: July 29, 2022

MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30.

MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30.

Journal: Cellular & molecular biology letters

Published: June 13, 2022

Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade.

Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade.

Journal: Cell death & disease

Published: June 10, 2021

Progression of squamous cell carcinoma is regulated by miR-139-5p/CXCR4.

Progression of squamous cell carcinoma is regulated by miR-139-5p/CXCR4.

Journal: Frontiers in bioscience (Landmark edition)

Published: May 31, 2020

EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.

EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.

Journal: Theranostics

Published: April 19, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026